UBP47_HUMAN - dbPTM
UBP47_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UBP47_HUMAN
UniProt AC Q96K76
Protein Name Ubiquitin carboxyl-terminal hydrolase 47
Gene Name USP47
Organism Homo sapiens (Human).
Sequence Length 1375
Subcellular Localization Cytoplasm .
Protein Description Ubiquitin-specific protease that specifically deubiquitinates monoubiquitinated DNA polymerase beta (POLB), stabilizing POLB thereby playing a role in base-excision repair (BER). Acts as a regulator of cell growth and genome integrity. May also indirectly regulate CDC25A expression at a transcriptional level..
Protein Sequence MVPGEENQLVPKEDVFWRCRQNIFDEMKKKFLQIENAAEEPRVLCIIQDTTNSKTVNERITLNLPASTPVRKLFEDVANKVGYINGTFDLVWGNGINTADMAPLDHTSDKSLLDANFEPGKKNFLHLTDKDGEQPQILLEDSSAGEDSVHDRFIGPLPREGSGGSTSDYVSQSYSYSSILNKSETGYVGLVNQAMTCYLNSLLQTLFMTPEFRNALYKWEFEESEEDPVTSIPYQLQRLFVLLQTSKKRAIETTDVTRSFGWDSSEAWQQHDVQELCRVMFDALEQKWKQTEQADLINELYQGKLKDYVRCLECGYEGWRIDTYLDIPLVIRPYGSSQAFASVEEALHAFIQPEILDGPNQYFCERCKKKCDARKGLRFLHFPYLLTLQLKRFDFDYTTMHRIKLNDRMTFPEELDMSTFIDVEDEKSPQTESCTDSGAENEGSCHSDQMSNDFSNDDGVDEGICLETNSGTEKISKSGLEKNSLIYELFSVMVHSGSAAGGHYYACIKSFSDEQWYSFNDQHVSRITQEDIKKTHGGSSGSRGYYSSAFASSTNAYMLIYRLKDPARNAKFLEVDEYPEHIKNLVQKERELEEQEKRQREIERNTCKIKLFCLHPTKQVMMENKLEVHKDKTLKEAVEMAYKMMDLEEVIPLDCCRLVKYDEFHDYLERSYEGEEDTPMGLLLGGVKSTYMFDLLLETRKPDQVFQSYKPGEVMVKVHVVDLKAESVAAPITVRAYLNQTVTEFKQLISKAIHLPAETMRIVLERCYNDLRLLSVSSKTLKAEGFFRSNKVFVESSETLDYQMAFADSHLWKLLDRHANTIRLFVLLPEQSPVSYSKRTAYQKAGGDSGNVDDDCERVKGPVGSLKSVEAILEESTEKLKSLSLQQQQDGDNGDSSKSTETSDFENIESPLNERDSSASVDNRELEQHIQTSDPENFQSEERSDSDVNNDRSTSSVDSDILSSSHSSDTLCNADNAQIPLANGLDSHSITSSRRTKANEGKKETWDTAEEDSGTDSEYDESGKSRGEMQYMYFKAEPYAADEGSGEGHKWLMVHVDKRITLAAFKQHLEPFVGVLSSHFKVFRVYASNQEFESVRLNETLSSFSDDNKITIRLGRALKKGEYRVKVYQLLVNEQEPCKFLLDAVFAKGMTVRQSKEELIPQLREQCGLELSIDRFRLRKKTWKNPGTVFLDYHIYEEDINISSNWEVFLEVLDGVEKMKSMSQLAVLSRRWKPSEMKLDPFQEVVLESSSVDELREKLSEISGIPLDDIEFAKGRGTFPCDISVLDIHQDLDWNPKVSTLNVWPLYICDDGAVIFYRDKTEELMELTDEQRNELMKKESSRLQKTGHRVTYSPRKEKALKIYLDGAPNKDLTQD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
34UbiquitinationMKKKFLQIENAAEEP
HHHHHHHHHCCCCCC
4.8521890473
34AcetylationMKKKFLQIENAAEEP
HHHHHHHHHCCCCCC
4.8519608861
34UbiquitinationMKKKFLQIENAAEEP
HHHHHHHHHCCCCCC
4.8519608861
34 (in isoform 2)Acetylation-4.85-
34 (in isoform 2)Ubiquitination-4.8521890473
54 (in isoform 2)Phosphorylation-59.5724719451
55 (in isoform 2)Phosphorylation-28.5227251275
67PhosphorylationITLNLPASTPVRKLF
EEECCCCCCHHHHHH
31.1626270265
68PhosphorylationTLNLPASTPVRKLFE
EECCCCCCHHHHHHH
28.1025159151
77 (in isoform 2)Phosphorylation-5.0727251275
101UbiquitinationNGINTADMAPLDHTS
CCCCHHCCCCCCCCC
3.72-
102AcetylationGINTADMAPLDHTSD
CCCHHCCCCCCCCCC
11.31-
102UbiquitinationGINTADMAPLDHTSD
CCCHHCCCCCCCCCC
11.31-
102AcetylationGINTADMAPLDHTSD
CCCHHCCCCCCCCCC
11.3119608861
102UbiquitinationGINTADMAPLDHTSD
CCCHHCCCCCCCCCC
11.3119608861
111PhosphorylationLDHTSDKSLLDANFE
CCCCCCHHHHHCCCC
38.8728555341
121AcetylationDANFEPGKKNFLHLT
HCCCCCCCCCEEEEE
56.0825953088
122AcetylationANFEPGKKNFLHLTD
CCCCCCCCCEEEEEC
59.8719608861
122PhosphorylationANFEPGKKNFLHLTD
CCCCCCCCCEEEEEC
59.87-
122UbiquitinationANFEPGKKNFLHLTD
CCCCCCCCCEEEEEC
59.8721890473
122 (in isoform 1)Ubiquitination-59.8721890473
123PhosphorylationNFEPGKKNFLHLTDK
CCCCCCCCEEEEECC
48.47-
128PhosphorylationKKNFLHLTDKDGEQP
CCCEEEEECCCCCCC
30.2029978859
130UbiquitinationNFLHLTDKDGEQPQI
CEEEEECCCCCCCEE
63.50-
136 (in isoform 2)Phosphorylation-38.3624719451
142PhosphorylationPQILLEDSSAGEDSV
CEEEEECCCCCCCCC
16.8323401153
143PhosphorylationQILLEDSSAGEDSVH
EEEEECCCCCCCCCC
53.2525159151
146 (in isoform 2)Phosphorylation-46.9924719451
148PhosphorylationDSSAGEDSVHDRFIG
CCCCCCCCCCCCCCC
19.6323663014
162PhosphorylationGPLPREGSGGSTSDY
CCCCCCCCCCCHHHH
34.9228857561
165PhosphorylationPREGSGGSTSDYVSQ
CCCCCCCCHHHHCCC
28.4118669648
166PhosphorylationREGSGGSTSDYVSQS
CCCCCCCHHHHCCCC
28.9728857561
167PhosphorylationEGSGGSTSDYVSQSY
CCCCCCHHHHCCCCE
28.7428857561
169PhosphorylationSGGSTSDYVSQSYSY
CCCCHHHHCCCCEEC
11.19-
174PhosphorylationSDYVSQSYSYSSILN
HHHCCCCEECHHHCC
12.18-
176PhosphorylationYVSQSYSYSSILNKS
HCCCCEECHHHCCCC
9.75-
178PhosphorylationSQSYSYSSILNKSET
CCCEECHHHCCCCCC
23.9024719451
183PhosphorylationYSSILNKSETGYVGL
CHHHCCCCCCCCHHH
39.0424043423
185PhosphorylationSILNKSETGYVGLVN
HHCCCCCCCCHHHHH
40.6924043423
187PhosphorylationLNKSETGYVGLVNQA
CCCCCCCCHHHHHHH
9.9624043423
196PhosphorylationGLVNQAMTCYLNSLL
HHHHHHHHHHHHHHH
10.8724043423
198PhosphorylationVNQAMTCYLNSLLQT
HHHHHHHHHHHHHHH
10.3524043423
199UbiquitinationNQAMTCYLNSLLQTL
HHHHHHHHHHHHHHH
3.6921890473
199 (in isoform 2)Ubiquitination-3.6921890473
201PhosphorylationAMTCYLNSLLQTLFM
HHHHHHHHHHHHHHC
28.0624043423
205PhosphorylationYLNSLLQTLFMTPEF
HHHHHHHHHHCCHHH
23.1824043423
209PhosphorylationLLQTLFMTPEFRNAL
HHHHHHCCHHHHHHH
16.6024043423
214PhosphorylationFMTPEFRNALYKWEF
HCCHHHHHHHHHEEC
39.35-
224PhosphorylationYKWEFEESEEDPVTS
HHEECCCCCCCCCCC
38.8024719451
234PhosphorylationDPVTSIPYQLQRLFV
CCCCCHHHHHHHHHH
21.8624719451
267UbiquitinationFGWDSSEAWQQHDVQ
CCCCCHHHHHHHCHH
16.01-
267UbiquitinationFGWDSSEAWQQHDVQ
CCCCCHHHHHHHCHH
16.01-
269UbiquitinationWDSSEAWQQHDVQEL
CCCHHHHHHHCHHHH
37.47-
269UbiquitinationWDSSEAWQQHDVQEL
CCCHHHHHHHCHHHH
37.47-
284UbiquitinationCRVMFDALEQKWKQT
HHHHHHHHHHHHHHH
8.46-
287UbiquitinationMFDALEQKWKQTEQA
HHHHHHHHHHHHHHH
47.1621890473
287 (in isoform 1)Ubiquitination-47.1621890473
289UbiquitinationDALEQKWKQTEQADL
HHHHHHHHHHHHHHH
55.14-
304UbiquitinationINELYQGKLKDYVRC
HHHHHHCCHHHHHHH
36.52-
323PhosphorylationYEGWRIDTYLDIPLV
CCCEEEEEEEECCEE
24.5029978859
324PhosphorylationEGWRIDTYLDIPLVI
CCEEEEEEEECCEEE
9.9129978859
384PhosphorylationLRFLHFPYLLTLQLK
CHHHCHHHHEEEECC
17.25-
387PhosphorylationLHFPYLLTLQLKRFD
HCHHHHEEEECCCCC
15.18-
397PhosphorylationLKRFDFDYTTMHRIK
CCCCCCCCCEEEEEE
12.24-
398PhosphorylationKRFDFDYTTMHRIKL
CCCCCCCCEEEEEEC
21.35-
399PhosphorylationRFDFDYTTMHRIKLN
CCCCCCCEEEEEECC
12.54-
404AcetylationYTTMHRIKLNDRMTF
CCEEEEEECCCCCCC
40.997932683
435PhosphorylationSPQTESCTDSGAENE
CCCCCCCCCCCCCCC
42.3428348404
437PhosphorylationQTESCTDSGAENEGS
CCCCCCCCCCCCCCC
23.0428348404
440 (in isoform 2)Phosphorylation-60.38-
444PhosphorylationSGAENEGSCHSDQMS
CCCCCCCCCCCHHCC
11.5028348404
447PhosphorylationENEGSCHSDQMSNDF
CCCCCCCCHHCCCCC
33.5928348404
451PhosphorylationSCHSDQMSNDFSNDD
CCCCHHCCCCCCCCC
27.8428348404
455PhosphorylationDQMSNDFSNDDGVDE
HHCCCCCCCCCCCCC
42.0628348404
457UbiquitinationMSNDFSNDDGVDEGI
CCCCCCCCCCCCCCC
53.49-
487PhosphorylationLEKNSLIYELFSVMV
CCCCCHHHHHHHHHH
16.33-
504PhosphorylationGSAAGGHYYACIKSF
CCCCCCEEEEEEEEC
8.95-
505PhosphorylationSAAGGHYYACIKSFS
CCCCCEEEEEEEECC
6.85-
508PhosphorylationGGHYYACIKSFSDEQ
CCEEEEEEEECCCHH
2.9719664994
513UbiquitinationACIKSFSDEQWYSFN
EEEEECCCHHCCCCC
50.53-
528PhosphorylationDQHVSRITQEDIKKT
HHHHHHCCHHHHHHH
25.4619664994
533UbiquitinationRITQEDIKKTHGGSS
HCCHHHHHHHCCCCC
65.03-
535PhosphorylationTQEDIKKTHGGSSGS
CHHHHHHHCCCCCCC
22.28-
539PhosphorylationIKKTHGGSSGSRGYY
HHHHCCCCCCCCCCC
35.80-
540PhosphorylationKKTHGGSSGSRGYYS
HHHCCCCCCCCCCCH
44.0230576142
546PhosphorylationSSGSRGYYSSAFASS
CCCCCCCCHHCCCCC
10.0418083107
547PhosphorylationSGSRGYYSSAFASST
CCCCCCCHHCCCCCC
13.5030576142
548PhosphorylationGSRGYYSSAFASSTN
CCCCCCHHCCCCCCC
15.9830576142
551UbiquitinationGYYSSAFASSTNAYM
CCCHHCCCCCCCEEE
11.42-
551UbiquitinationGYYSSAFASSTNAYM
CCCHHCCCCCCCEEE
11.42-
557PhosphorylationFASSTNAYMLIYRLK
CCCCCCEEEEEEEEC
8.4318083107
561PhosphorylationTNAYMLIYRLKDPAR
CCEEEEEEEECCHHH
13.1118083107
563UbiquitinationAYMLIYRLKDPARNA
EEEEEEEECCHHHCC
4.07-
568UbiquitinationYRLKDPARNAKFLEV
EEECCHHHCCCEEEH
49.37-
571UbiquitinationKDPARNAKFLEVDEY
CCHHHCCCEEEHHHC
54.77-
572UbiquitinationDPARNAKFLEVDEYP
CHHHCCCEEEHHHCH
6.9921890473
572 (in isoform 2)Ubiquitination-6.9921890473
590UbiquitinationKNLVQKERELEEQEK
HHHHHHHHHHHHHHH
61.92-
598UbiquitinationELEEQEKRQREIERN
HHHHHHHHHHHHHHH
39.78-
610AcetylationERNTCKIKLFCLHPT
HHHHCEEEEEECCCC
22.4725953088
618AcetylationLFCLHPTKQVMMENK
EEECCCCHHHHHHCC
45.4025953088
640UbiquitinationTLKEAVEMAYKMMDL
HHHHHHHHHHHHCCH
3.87-
640UbiquitinationTLKEAVEMAYKMMDL
HHHHHHHHHHHHCCH
3.87-
660AcetylationLDCCRLVKYDEFHDY
CCHHHEEEHHHHHHH
52.1325953088
660UbiquitinationLDCCRLVKYDEFHDY
CCHHHEEEHHHHHHH
52.1321890473
660 (in isoform 1)Ubiquitination-52.1321890473
661PhosphorylationDCCRLVKYDEFHDYL
CHHHEEEHHHHHHHH
17.1528851738
662 (in isoform 2)Phosphorylation-46.5024719451
689PhosphorylationLLLGGVKSTYMFDLL
HCCCCCCHHHHHHHH
23.5122210691
689 (in isoform 2)Phosphorylation-23.5124719451
690PhosphorylationLLGGVKSTYMFDLLL
CCCCCCHHHHHHHHH
17.1822210691
690 (in isoform 2)Phosphorylation-17.1824719451
691PhosphorylationLGGVKSTYMFDLLLE
CCCCCHHHHHHHHHC
11.6822210691
704UbiquitinationLETRKPDQVFQSYKP
HCCCCCCCCCCCCCC
46.59-
704UbiquitinationLETRKPDQVFQSYKP
HCCCCCCCCCCCCCC
46.59-
708PhosphorylationKPDQVFQSYKPGEVM
CCCCCCCCCCCCCEE
24.5322210691
710AcetylationDQVFQSYKPGEVMVK
CCCCCCCCCCCEEEE
52.3625953088
724UbiquitinationKVHVVDLKAESVAAP
EEEEEECCCCCCCCC
45.72-
727PhosphorylationVVDLKAESVAAPITV
EEECCCCCCCCCHHH
23.1621406692
733PhosphorylationESVAAPITVRAYLNQ
CCCCCCHHHHHHHCC
11.6821406692
743PhosphorylationAYLNQTVTEFKQLIS
HHHCCHHHHHHHHHH
38.81-
744 (in isoform 2)Phosphorylation-46.6524719451
747 (in isoform 2)Phosphorylation-49.7227251275
748 (in isoform 2)Phosphorylation-5.00-
750PhosphorylationTEFKQLISKAIHLPA
HHHHHHHHHHHCCCH
25.3224719451
762UbiquitinationLPAETMRIVLERCYN
CCHHHHHHHHHHHHC
2.62-
762UbiquitinationLPAETMRIVLERCYN
CCHHHHHHHHHHHHC
2.62-
777PhosphorylationDLRLLSVSSKTLKAE
CHHHEEEECCCCCEE
23.8124719451
777 (in isoform 2)Phosphorylation-23.8124719451
778PhosphorylationLRLLSVSSKTLKAEG
HHHEEEECCCCCEEC
27.7524719451
779AcetylationRLLSVSSKTLKAEGF
HHEEEECCCCCEECC
50.8225953088
780PhosphorylationLLSVSSKTLKAEGFF
HEEEECCCCCEECCC
35.12-
780 (in isoform 2)Phosphorylation-35.1227251275
782AcetylationSVSSKTLKAEGFFRS
EEECCCCCEECCCCC
50.0125953088
782MalonylationSVSSKTLKAEGFFRS
EEECCCCCEECCCCC
50.0126320211
782UbiquitinationSVSSKTLKAEGFFRS
EEECCCCCEECCCCC
50.01-
788 (in isoform 2)Phosphorylation-36.7427251275
789 (in isoform 2)Phosphorylation-35.53-
797MethylationNKVFVESSETLDYQM
CCEEEECCCCCCHHH
22.54-
808 (in isoform 2)Phosphorylation-30.0927251275
812PhosphorylationAFADSHLWKLLDRHA
HHCHHHHHHHHHHHC
5.4820068231
815PhosphorylationDSHLWKLLDRHANTI
HHHHHHHHHHHCCEE
4.8918669648
815 (in isoform 2)Phosphorylation-4.8927251275
816PhosphorylationSHLWKLLDRHANTIR
HHHHHHHHHHCCEEE
51.2418691976
817MethylationHLWKLLDRHANTIRL
HHHHHHHHHCCEEEE
30.68115919641
817PhosphorylationHLWKLLDRHANTIRL
HHHHHHHHHCCEEEE
30.68-
818UbiquitinationLWKLLDRHANTIRLF
HHHHHHHHCCEEEEE
24.01-
818UbiquitinationLWKLLDRHANTIRLF
HHHHHHHHCCEEEEE
24.01-
822 (in isoform 2)Phosphorylation-3.4624719451
824UbiquitinationRHANTIRLFVLLPEQ
HHCCEEEEEEECCCC
2.84-
824UbiquitinationRHANTIRLFVLLPEQ
HHCCEEEEEEECCCC
2.84-
829 (in isoform 2)Phosphorylation-33.16-
830 (in isoform 2)Phosphorylation-64.76-
832PhosphorylationFVLLPEQSPVSYSKR
EEECCCCCCCCCCHH
26.1329255136
835PhosphorylationLPEQSPVSYSKRTAY
CCCCCCCCCCHHCHH
27.3729255136
836PhosphorylationPEQSPVSYSKRTAYQ
CCCCCCCCCHHCHHH
20.6028176443
837PhosphorylationEQSPVSYSKRTAYQK
CCCCCCCCHHCHHHH
14.2529255136
838AcetylationQSPVSYSKRTAYQKA
CCCCCCCHHCHHHHC
45.6025953088
838UbiquitinationQSPVSYSKRTAYQKA
CCCCCCCHHCHHHHC
45.60-
840UbiquitinationPVSYSKRTAYQKAGG
CCCCCHHCHHHHCCC
33.19-
844UbiquitinationSKRTAYQKAGGDSGN
CHHCHHHHCCCCCCC
36.00-
844 (in isoform 2)Phosphorylation-36.0024719451
845PhosphorylationKRTAYQKAGGDSGNV
HHCHHHHCCCCCCCC
16.21-
845 (in isoform 2)Phosphorylation-16.2127251275
847UbiquitinationTAYQKAGGDSGNVDD
CHHHHCCCCCCCCCC
30.67-
848PhosphorylationAYQKAGGDSGNVDDD
HHHHCCCCCCCCCCC
53.07-
849PhosphorylationYQKAGGDSGNVDDDC
HHHCCCCCCCCCCCH
35.2321815630
856PhosphorylationSGNVDDDCERVKGPV
CCCCCCCHHHCCCCC
4.6518669648
856 (in isoform 2)Phosphorylation-4.6524719451
857PhosphorylationGNVDDDCERVKGPVG
CCCCCCHHHCCCCCC
68.4518669648
861UbiquitinationDDCERVKGPVGSLKS
CCHHHCCCCCCCHHH
21.19-
865PhosphorylationRVKGPVGSLKSVEAI
HCCCCCCCHHHHHHH
32.6228060719
868PhosphorylationGPVGSLKSVEAILEE
CCCCCHHHHHHHHHH
30.4029396449
876PhosphorylationVEAILEESTEKLKSL
HHHHHHHHHHHHHHC
32.2725159151
877PhosphorylationEAILEESTEKLKSLS
HHHHHHHHHHHHHCC
40.1821815630
879 (in isoform 2)Phosphorylation-62.3927251275
883PhosphorylationSTEKLKSLSLQQQQD
HHHHHHHCCHHHCCC
5.91-
890PhosphorylationLSLQQQQDGDNGDSS
CCHHHCCCCCCCCCC
63.1719664994
896PhosphorylationQDGDNGDSSKSTETS
CCCCCCCCCCCCCCC
40.8525159151
897PhosphorylationDGDNGDSSKSTETSD
CCCCCCCCCCCCCCC
35.0521815630
898PhosphorylationGDNGDSSKSTETSDF
CCCCCCCCCCCCCCC
66.4118669648
899PhosphorylationDNGDSSKSTETSDFE
CCCCCCCCCCCCCCC
33.1629632367
900PhosphorylationNGDSSKSTETSDFEN
CCCCCCCCCCCCCCC
47.2029632367
902PhosphorylationDSSKSTETSDFENIE
CCCCCCCCCCCCCCC
33.4129632367
903PhosphorylationSSKSTETSDFENIES
CCCCCCCCCCCCCCC
33.7928176443
910PhosphorylationSDFENIESPLNERDS
CCCCCCCCCCCCCCC
30.7819664994
912PhosphorylationFENIESPLNERDSSA
CCCCCCCCCCCCCCC
16.8919651622
913PhosphorylationENIESPLNERDSSAS
CCCCCCCCCCCCCCC
45.7119651622
917PhosphorylationSPLNERDSSASVDNR
CCCCCCCCCCCCCHH
33.7418669648
918PhosphorylationPLNERDSSASVDNRE
CCCCCCCCCCCCHHH
28.9318669648
920PhosphorylationNERDSSASVDNRELE
CCCCCCCCCCHHHHH
31.7723186163
924PhosphorylationSSASVDNRELEQHIQ
CCCCCCHHHHHHHHH
45.47-
925 (in isoform 2)Phosphorylation-64.0124719451
927 (in isoform 2)Phosphorylation-35.0524719451
929 (in isoform 2)Phosphorylation-12.54-
932PhosphorylationELEQHIQTSDPENFQ
HHHHHHHCCCCCCCC
34.2030266825
933PhosphorylationLEQHIQTSDPENFQS
HHHHHHCCCCCCCCC
34.4929255136
937 (in isoform 2)Phosphorylation-45.7227251275
940PhosphorylationSDPENFQSEERSDSD
CCCCCCCCCCCCCCC
36.9723401153
944PhosphorylationNFQSEERSDSDVNND
CCCCCCCCCCCCCCC
44.7530266825
946PhosphorylationQSEERSDSDVNNDRS
CCCCCCCCCCCCCCC
44.7130266825
953PhosphorylationSDVNNDRSTSSVDSD
CCCCCCCCCCCCCHH
35.1928270605
954PhosphorylationDVNNDRSTSSVDSDI
CCCCCCCCCCCCHHH
26.3928270605
955PhosphorylationVNNDRSTSSVDSDIL
CCCCCCCCCCCHHHH
29.6128270605
956PhosphorylationNNDRSTSSVDSDILS
CCCCCCCCCCHHHHC
29.9929496963
959PhosphorylationRSTSSVDSDILSSSH
CCCCCCCHHHHCCCC
25.1328270605
963PhosphorylationSVDSDILSSSHSSDT
CCCHHHHCCCCCCCC
30.0828270605
964PhosphorylationVDSDILSSSHSSDTL
CCHHHHCCCCCCCCC
28.7328270605
965PhosphorylationDSDILSSSHSSDTLC
CHHHHCCCCCCCCCC
24.8228270605
967PhosphorylationDILSSSHSSDTLCNA
HHHCCCCCCCCCCCC
31.6828857561
968PhosphorylationILSSSHSSDTLCNAD
HHCCCCCCCCCCCCC
29.2328270605
970PhosphorylationSSSHSSDTLCNADNA
CCCCCCCCCCCCCCC
34.8528270605
970 (in isoform 2)Ubiquitination-34.8521890473
985PhosphorylationQIPLANGLDSHSITS
CCCCCCCCCCCCCCC
6.48-
993PhosphorylationDSHSITSSRRTKANE
CCCCCCCCCCCCCCC
19.6819651622
995PhosphorylationHSITSSRRTKANEGK
CCCCCCCCCCCCCCC
42.3919651622
997PhosphorylationITSSRRTKANEGKKE
CCCCCCCCCCCCCCC
47.6119651622
1005PhosphorylationANEGKKETWDTAEED
CCCCCCCCCCCCCCC
37.2023403867
1008PhosphorylationGKKETWDTAEEDSGT
CCCCCCCCCCCCCCC
27.7725072903
1013PhosphorylationWDTAEEDSGTDSEYD
CCCCCCCCCCCCCCC
47.0422617229
1015PhosphorylationTAEEDSGTDSEYDES
CCCCCCCCCCCCCCC
40.0622617229
1017PhosphorylationEEDSGTDSEYDESGK
CCCCCCCCCCCCCCC
37.5828102081
1019PhosphorylationDSGTDSEYDESGKSR
CCCCCCCCCCCCCCC
29.0323663014
1022PhosphorylationTDSEYDESGKSRGEM
CCCCCCCCCCCCCEE
48.9323663014
1025PhosphorylationEYDESGKSRGEMQYM
CCCCCCCCCCEEEEE
49.3928450419
1038UbiquitinationYMYFKAEPYAADEGS
EEEEEECCCCCCCCC
28.99-
1038UbiquitinationYMYFKAEPYAADEGS
EEEEEECCCCCCCCC
28.99-
1058UbiquitinationWLMVHVDKRITLAAF
EEEEECCCCCHHHHH
44.612190698
1058 (in isoform 1)Ubiquitination-44.6121890473
1068PhosphorylationTLAAFKQHLEPFVGV
HHHHHHHHHHHHHHH
32.52-
1086PhosphorylationHFKVFRVYASNQEFE
CEEEEEEEECCCCEE
10.4724117733
1088PhosphorylationKVFRVYASNQEFESV
EEEEEEECCCCEEEE
22.7421815630
1094PhosphorylationASNQEFESVRLNETL
ECCCCEEEEECCCCH
20.1924117733
1100PhosphorylationESVRLNETLSSFSDD
EEEECCCCHHHCCCC
30.7620873877
1102PhosphorylationVRLNETLSSFSDDNK
EECCCCHHHCCCCCC
36.4420873877
1103O-linked_GlycosylationRLNETLSSFSDDNKI
ECCCCHHHCCCCCCE
31.7023301498
1103PhosphorylationRLNETLSSFSDDNKI
ECCCCHHHCCCCCCE
31.7020873877
1105O-linked_GlycosylationNETLSSFSDDNKITI
CCCHHHCCCCCCEEE
46.1023301498
1105PhosphorylationNETLSSFSDDNKITI
CCCHHHCCCCCCEEE
46.1020873877
1111PhosphorylationFSDDNKITIRLGRAL
CCCCCCEEEEECHHH
11.1428258704
1123PhosphorylationRALKKGEYRVKVYQL
HHHHCCCEEEEEEEH
29.40-
1133 (in isoform 2)Phosphorylation-45.24-
1135 (in isoform 2)Phosphorylation-55.52-
1136UbiquitinationQLLVNEQEPCKFLLD
EHHHCCCCCCHHHHH
46.62-
1155PhosphorylationKGMTVRQSKEELIPQ
CCCCHHHCHHHHHHH
31.3226270265
1201PhosphorylationHIYEEDINISSNWEV
EEECCCCCCCCCHHH
40.1720068231
1203PhosphorylationYEEDINISSNWEVFL
ECCCCCCCCCHHHHH
17.0920068231
1221PhosphorylationDGVEKMKSMSQLAVL
HHHHHHHCHHHHHHH
21.8420068231
1222SulfoxidationGVEKMKSMSQLAVLS
HHHHHHCHHHHHHHH
2.1721406390
1223PhosphorylationVEKMKSMSQLAVLSR
HHHHHCHHHHHHHHC
29.1820068231
1229PhosphorylationMSQLAVLSRRWKPSE
HHHHHHHHCCCCCHH
17.1320068231
1233 (in isoform 2)Phosphorylation-36.53-
1238UbiquitinationRWKPSEMKLDPFQEV
CCCCHHCCCCCHHHH
45.76-
1252 (in isoform 2)Phosphorylation-7.7724719451
1254UbiquitinationLESSSVDELREKLSE
HHCCCHHHHHHHHHH
47.79-
1254UbiquitinationLESSSVDELREKLSE
HHCCCHHHHHHHHHH
47.79-
1264 (in isoform 2)Phosphorylation-31.06-
1265 (in isoform 2)Phosphorylation-2.1524719451
1274AcetylationLDDIEFAKGRGTFPC
HHHCHHCCCCCCCCC
55.2325953088
1274UbiquitinationLDDIEFAKGRGTFPC
HHHCHHCCCCCCCCC
55.23-
1301PhosphorylationWNPKVSTLNVWPLYI
CCCCCCEECEEEEEE
3.6620068231
1321PhosphorylationVIFYRDKTEELMELT
EEEEECCHHHHHHCC
38.6920068231
1325SulfoxidationRDKTEELMELTDEQR
ECCHHHHHHCCHHHH
4.4821406390
1328PhosphorylationTEELMELTDEQRNEL
HHHHHHCCHHHHHHH
24.9620068231
1332PhosphorylationMELTDEQRNELMKKE
HHCCHHHHHHHHHHH
36.2220068231
1333PhosphorylationELTDEQRNELMKKES
HCCHHHHHHHHHHHH
46.5818088087
1337AcetylationEQRNELMKKESSRLQ
HHHHHHHHHHHHHHH
67.047667085
1340PhosphorylationNELMKKESSRLQKTG
HHHHHHHHHHHHHHC
29.6324719451
1341PhosphorylationELMKKESSRLQKTGH
HHHHHHHHHHHHHCC
37.79-
1343PhosphorylationMKKESSRLQKTGHRV
HHHHHHHHHHHCCCC
7.09-
1346PhosphorylationESSRLQKTGHRVTYS
HHHHHHHHCCCCCCC
25.8423312004
1351PhosphorylationQKTGHRVTYSPRKEK
HHHCCCCCCCCCHHH
20.4521815630
1352PhosphorylationKTGHRVTYSPRKEKA
HHCCCCCCCCCHHHH
17.5120068231
1353PhosphorylationTGHRVTYSPRKEKAL
HCCCCCCCCCHHHHH
14.6321712546
1363PhosphorylationKEKALKIYLDGAPNK
HHHHHHEECCCCCCC
9.3525159151
1373PhosphorylationGAPNKDLTQD-----
CCCCCCCCCC-----
40.6029214152

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseBTRCQ9Y297
PMID:24658274

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UBP47_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UBP47_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KTNA1_HUMANKATNA1physical
23904609
VATH_HUMANATP6V1Hphysical
22863883
GMPPB_HUMANGMPPBphysical
22863883
PDXD1_HUMANPDXDC1physical
22863883
WDR44_HUMANWDR44physical
22863883
PA2GA_HUMANPLA2G2Aphysical
22118674
RECQ1_HUMANRECQLphysical
28514442
LETM1_HUMANLETM1physical
28514442
CTBL1_HUMANCTNNBL1physical
28514442
VRK1_HUMANVRK1physical
28514442
RBM12_HUMANRBM12physical
28514442
LYPA1_HUMANLYPLA1physical
28514442
MCTS1_HUMANMCTS1physical
28514442
NAA15_HUMANNAA15physical
28514442
PP1R8_HUMANPPP1R8physical
28514442
OTUB1_HUMANOTUB1physical
28514442
TOM34_HUMANTOMM34physical
28514442
SNX3_HUMANSNX3physical
28514442
IST1_HUMANIST1physical
28514442
SYNC_HUMANNARSphysical
28514442
NB5R3_HUMANCYB5R3physical
28514442
RPR1B_HUMANRPRD1Bphysical
28514442
NSDHL_HUMANNSDHLphysical
28514442
VIGLN_HUMANHDLBPphysical
28514442
GATA_HUMANQRSL1physical
28514442
DENR_HUMANDENRphysical
28514442
ERF1_HUMANETF1physical
28514442
PUR8_HUMANADSLphysical
28514442
CLPP_HUMANCLPPphysical
28514442
VAMP3_HUMANVAMP3physical
28514442
FEN1_HUMANFEN1physical
28514442
MDC1_HUMANMDC1physical
28514442
TCEA1_HUMANTCEA1physical
28514442
LRC40_HUMANLRRC40physical
28514442
RPR1A_HUMANRPRD1Aphysical
28514442
2A5D_HUMANPPP2R5Dphysical
28514442
SNX6_HUMANSNX6physical
28514442
DNJC2_HUMANDNAJC2physical
28514442
PAK2_HUMANPAK2physical
28514442
TRUA_HUMANPUS1physical
28514442
RAD21_HUMANRAD21physical
28514442
SYAP1_HUMANSYAP1physical
28514442
EF1A2_HUMANEEF1A2physical
28514442
PLSI_HUMANPLS1physical
28514442
NUP53_HUMANNUP35physical
28514442
SYFB_HUMANFARSBphysical
28514442
EEA1_HUMANEEA1physical
28514442
HMGN5_HUMANHMGN5physical
28514442
HELLS_HUMANHELLSphysical
28514442
SF3A3_HUMANSF3A3physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UBP47_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-122, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832 AND SER-910, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832 AND SER-910, ANDMASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1353, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-836, AND MASSSPECTROMETRY.

TOP